PETER G. SAVAS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2008-10-15 Mr. Savas is Chairman and Chief Executive Officer of Alseres Pharmaceuticals, Inc.... Mr. Savas served as CEO and President of Aderis Pharmaceuticals, Inc.
2009-10-13 Mr. Savas is Chairman and Chief Executive Officer of Alseres Pharmaceuticals, Inc... Mr. Savas served as CEO and President of Aderis Pharmaceuticals, Inc. and President and CEO of Unisyn, Inc.
2010-10-25 Mr. Savas’ significant experience leading life sciences companies brings valuable insight to the strategy, operations and management of pSvida.
2011-10-25 Mr. Savas’ significant experience leading life sciences companies focused on the development of new products brings valuable insight to the strategy, operations and management of pSivida.
2012-10-25 Mr. Savas’ significant experience leading life sciences companies focused on the development of new products brings valuable insight to the strategy, operations and management of pSivida.
2013-10-25 Mr. Savas’ significant experience leading life sciences companies focused on the development of new products brings valuable insight to the strategy, operations and management of pSivida.
2014-10-24 Mr. Savas is Chairman and Chief Executive Officer of Alseres Pharmaceuticals, Inc., a company focused on the development of diagnostic and therapeutic products for disorders in the central nervous system, a position that he has held since September 2004.
2015-10-23 Mr. Savas’ significant experience leading life sciences companies focused on the development of new products brings valuable insight to the strategy, operations and management of pSivida.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25